Fasting Indicators of Insulin Sensitivity: Effects of Ethnicity and Pubertal Status by Adam, Tanja C. et al.
Fasting Indicators of Insulin Sensitivity:
Effects of Ethnicity and Pubertal Status
TANJA C. ADAM, PHD
1
REBECCA E. HASSON, PHD
2
CHRISTIANNE J. LANE, PHD
1
JAIMIE N. DAVIS, PHD
1
MARC J. WEIGENSBERG, MD
3
DONNA SPRUIJT-METZ, PHD
1
MICHAEL I. GORAN, PHD
1
OBJECTIVE—To examine the relationship of fasting indicators of insulin sensitivity with a
more invasive measure of insulin sensitivity (frequently sampled intravenous glucose tolerance
test [FSIVGTT]) and the effect of Tanner stage and ethnicity on that relationship.
RESEARCH DESIGN AND METHODS—Data were analyzed from 149 overweight girls
(97Hispanicand 52African American) who were either in theearlystages of maturation deﬁned
byTannerstages1or2(52Hispanicand18AfricanAmerican)orinthelaterstagesofmaturation
deﬁned by Tanner stages 4 and 5 (45 Hispanic and 34 African American). Fasting indicators of
insulin sensitivity (IS) included fasting insulin and glucose and the homeostasis model assess-
mentofinsulinresistance(HOMA-IR).ISwasderivedfromanFSIVGTTwithminimalmodeling.
RESULTS—InTannerstages1and2,allfastingindicatorsweresigniﬁcantlyassociatedwithIS:
(fasting insulin: r = 20.67,P , 0.01;HOMA:r = 20.66, P , 0.01) with no signiﬁcant inﬂuence
of ethnicity on these relationships. In Tanner stages 4 and 5, however, all fasting indicators were
associated with IS in African American girls (fasting insulin: r = 20.55, P , 0.01; HOMA: r =
20.47, P , 0.01), but none of the indicators were signiﬁcantly associated with IS in Hispanic
girls.
CONCLUSIONS—Fasting indicators were reﬂective of IS for girls in Tanner stages 1 and 2,
regardlessofethnicityandmayprovideaclinicalmeasureoffutureriskfortype2diabetes.Inthe
latter stages of maturation, however, more invasive measures are warranted to adequately de-
termine IS in clinical practice.
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T
he prevalence of type 2 diabetes has
dramatically increased in children
and adolescents, particularly within
the Hispanic and African American com-
munities (1). The incidence of cases in
high-risk ethnic populations accounts
for about 50% of all new cases of adoles-
cent diabetes diagnos e di nt h eU . S .( 2 ) .
Although the pathogenesis of type 2 di-
abetesinchildrenandadolescentshasnot
been described well, both insulin resis-
tance and the resulting compensatory hy-
perinsulinemia likely play an important
role as antecedents of type 2 diabetes
(3). African American and Hispanic chil-
d r e na r em o r ei n s u l i nr e s i s t a n tt h a nt h e i r
non-Hispanic white peers (4,5). The
increased prevalence of insulin resistance
and subsequent related metabolic com-
plications in these children pose an in-
creased risk for future morbidity later in
life. Considering the relevance of insulin
resistance for the development of type 2
diabetes and other metabolic complica-
tions,closemonitoringofinsulinsensitiv-
ity(IS)maybehelpfulinthepreventionof
the long-term complications associated
with insulin resistance, particularly in
at-risk populations.
The euglycemic-hyperinsulinemic
clamp (6) and the minimal modeling
analysis of the frequently sampled intra-
venous glucose tolerance test (FSIVGTT)
(7) are currently considered the gold
standard measures for the assessment of
IS. However, those measures are not eas-
ily applied in a large number of children
and adolescents because of their invasive-
ness, complexity, and related costs.
Therefore, a variety of measures derived
from fasting plasma and insulin concen-
trations have been proposed to simplify
the measurement of insulin sensitivity
(IS). The measures include the homeosta-
sis model assessment of insulin resistance
(HOMA-IR)(8)andsimplyfastinginsulin
concentrations. While being less invasive
and more feasible, the accuracy of proxy
measures has been questioned. Factors
suchasethnicity,puberty,andweightsta-
tus appear to affect the relationship of
fasting measures with direct measures of
IS (9). The most widely used surrogate
measures, their advantagesand disadvan-
tages, are summarized in a thorough re-
view by Cutﬁeld and Hofman (10). The
aimofthepresentanalysiswastoexamine
the relationship of the FSIVGTT in pre-
and postpubertal African American and
Hispanic girls.
RESEARCH DESIGN AND
METHODS—Baseline data from a total
of three studies were included from the
University of Southern California (USC)
Center for Transdisciplinary Research on
Energetics and Cancer (TREC). All stud-
ieswereperformedatUSC.Includedwere
girls from the Insulin Resistance and De-
clining Physical Activity Levels in African
American and Latina Girls Study (Tran-
sitions) (18 African American and 52
Hispanic girls) in Tanner stages 1 and 2.
Transitionsisalongitudinalassessmentof
physical activity in African American and
Hispanic girls through adolescence. Tan-
ner stages 4 and 5 included the Strength
and Nutrition Outcomes in Latino Ado-
lescents (SANO) (53 Hispanic girls) and
the Strength and Nutrition Outcomes in
African American Youth (STAND) (39
African American girls) studies (11).
Both studies examined the effect of a
randomized control trial, including the
combination of nutrition modiﬁcation
and strength training, on metabolic and
adiposity parameters in overweight His-
panic and African American teenagers. In
total, the analysis included 149 female,
overweight children and adolescents of
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ORIGINAL ARTICLEHispanic (n = 97) and African American
(n = 52) descent. Both ethnicities were
compared regarding the relationships of
fasting measures of IS with a more inva-
sive measure of IS (FSIVGTT) in Tanner
stages1and2aswellasinTannerstages4
and 5. Tanner stages 1 and 2 were com-
bined for the prepubertal and early pu-
berty group, and Tanner stages 4 and 5
were combined for the adolescent group.
Inclusion criteria for participants
were Hispanic or African American eth-
nicity, deﬁned by all four grandparents
being of Hispanic or African American
descent, and a BMI that was at or above
the 85th percentile for age and sex (12).
Participants were excluded from the
study if they had diabetes, suffered
from a major illness since birth, or had a
condition known to affect body composi-
tion or IS. Written informed consent was
obtained from parents and youth assent
from participants.
Anthropometric measures
A pediatric health care provider con-
ducted a medical history and physical
examination and determined maturation
using the criteria of Tanner at every
annual visit (13). Height was measured
to the nearest 0.1 cm by a wall-mounted
stadiometer, and weight was recorded to
thenearest0.1kgbyabalancebeammed-
icalscale.BMIandBMIpercentilesforage
and sex were determined based upon es-
tablished Centers for Disease Control
normative curves using Epi Info 2000,
version 1.1 (14).
Measures of IS. All girls participated in a
FSIVGTT, assessing IS, acute insulin re-
sponse (AIR), and disposition index (DI).
After a 12-h fasting period, intravenous
catheters were placed in an anticubital
vein in both arms. Two fasting blood
samples (215 and 25m i n )w e r ef o l -
lowed by a 0.3 g/kg body weight intrave-
nous glucose administration at timepoint
0. At 20 min, insulin (0.02 units/kg body
weight, Humulin R; Eli Lilly, Indianapo-
lis, IN) was intravenously administered.
Blood samples were taken at 2, 4, 8, 19,
22, 30, 40, 50, 70, 100, and 180 min. IS,
AIR, and DI as an indicator for b-cell ca-
pacity were calculated with MINMOD
Millennium 2003 (15). Blood samples
from the FSIVGTT were centrifuged for
10 min at 2,500 rpm and plasma aliquots
were frozen at 280°C until further anal-
ysis. Insulin concentrations were mea-
sured with a human insulin ELISA
(Linco, St. Charles, MO) (intraassay coef-
ﬁcient of variation: 4.7–7%, interassay
coefﬁcient of variation: 9.1–1%). The as-
say is a double antibody Sandwich ELISA
based on the capture of insulin to wells
of a microtiter plate coated with mono-
clonal mouse anti-human insulin anti-
bodies and the binding of a second
biotinylated monoclonal mouse anti-
human antibody to the captured insulin.
Glucose concentrations were measured
with the glucose oxidase technique (Yel-
low Springs Instrument analyzer; YIS
Inc., Yellow Springs, OH).
Body composition. Body composition
(total body fat and total lean mass) for all
participants was determined with dual-
energy X-ray absorptiometry using a
Hologic QDR 4500 W (Hologic, Bedford,
MA). Abdominal fat (visceral adipose
tissue, subcutaneous adipose tissue, and
hepatic fat fraction [HFF]) were assessed
by magnetic resonance imaging using a
General Electric 1.5 Tesla magnet
(Waukesha, WI). Multiple-slice axial TR
400/16viewoftheabdomenatthelevelof
the umbilicus was analyzed for volume of
adipose tissue (liter).
Fasting measures. Fasting measures
were calculated by taking the mean of
the two fasting blood samples (215 and
25) for glucose and insulin of the
FSIVGTT. The following fasting indices
were evaluated:
aÞ fasting insulin
¼ mean of two determinations ðmU=mLÞ
bÞ HOMA2IR
¼
fasting insulin ðmU=mLÞ3
fasting glucose ðmmol=LÞ
22:5
Data analysis. Descriptive statistics for
all variables of interest were determined
for both ethnic groups. Firstly, linear
regression modeling was used to deter-
mine whether ethnicity or Tanner stage
signiﬁcantly interact with the fasting
measures. Secondly, the relationship be-
tween IS and fasting measures was as-
sessed with partial Pearson correlations,
adjusted for age, fat mass, and fat-free
mass (FFM). P values of ,0.05 were con-
sidered to be statistically signiﬁcant. Re-
sults are expressed as means 6 SD.
RESULTS—Linear regression models
testing the relationship of ethnicity and
Tanner stage with fasting measures
showedasigniﬁcantinteractionofTanner
stage with fasting insulin (b = 1.19; P ,
0.01)and HOMA(b =1.12;P , 0.01) on
the relationship with IS. Therefore, Tan-
ner stages were separated into Tanner
stages 1 and 2 versus Tanner stages 4
and 5 and were tested separately for fur-
ther analysis.
No signiﬁcant interaction of ethnicity
with either fasting measure (fasting in-
sulin [b =0 . 2 4 ;P . 0.05] and HOMA
[b =0 . 2 9 ;P . 0.05]) was observed in
Tanner stages 1 and 2. Therefore African
American and Hispanic girls were ana-
lyzed together in that Tanner stage.
We did ﬁnd a signiﬁcant interaction
of ethnicity with both fasting insulin (b =
1.59; P , 0.01) and HOMA (b = 1.36;
P , 0.05), testing the relationship of fast-
ing measures with IS in Tanner stages 4
and5.Consequently,thisledtoaseparate
analysis of ethnicities in that group of
participants.
Characteristics for participants from
both ethnicities in Tanner stages 1 and 2
as well as Tanner stages 4 and 5 are
summarizedinTable1.InTannerstages1
and 2, African American girls had more
FFM and less visceral adipose tissue com-
pared with Hispanic girls. They also had
signiﬁcantly lower fasting glucose con-
centrations. African American girls were
not more insulin resistant according to IS
and HOMA, but they had a higher DI
compared with Hispanic girls. In Tanner
stages 4 and 5, African American girls
weighed more and had a higher FFM
compared with Hispanic girls. Hispanic
girls had higher fasting glucose and
lower DI compared withAfrican American
girls.
Tanner stages 1 and 2
Figure 1 shows the relationship of IS with
fasting measures for both ethnicities. In
partial correlations adjusting for age, fat,
and FFM, IS was signiﬁcantly correlated
with fasting insulin (r = 20.67;P , 0.01)
and HOMA (r = 20.66; P , 0.01) for all
participants.
Tanner stages 4 and 5
Figure 2 shows the relationship of IS and
fasting measures for both ethnicities, ad-
j u s t e df o ra g e ,f a tm a s s ,a n dF F M .F o r
African American girls, fasting insulin
(r = 20.55; P , 0.01) and HOMA (r =
20.47; P , 0.01) were signiﬁcantly asso-
ciatedwithIS.However,inHispanicgirls,
none of the fasting measures were associ-
ated with IS (fasting insulin: r = 20.09,
P = 0.55; HOMA: r = 0.12, P = 0.45).
For African American girls, fasting
insulin was associated with total fat mass
(r = 0.68; P , 0.01), total lean mass (r =
0.74; P , 0.01), and fasting glucose (r =
0.53; P , 0.01). In Hispanic girls, fasting
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(r = 0.35; P , 0.01), total lean mass (r =
0.42;P,0.01),butwasunrelatedtofast-
ing glucose. Fasting insulin was associ-
ated with HFF in both African American
(r=0.58;P,0.01)andHispanicgirls(r=
0.45; P , 0.01).
CONCLUSIONS—The aim of this
study was to examine the relationship of
fasting plasma markers of IS with IS
derived from a more invasive measure
(FSIVGTT) in ethnic minority girls. Our
results show that fasting indicators of IS
were modestly associated with IS derived
from the FSIVGTT in prepubertal and
early puberty girls, independent of eth-
nicity. In postpubertal adolescents how-
ever, fasting indicators were associated
with IS in African American girls, but not
in Hispanic girls.
Insulin sensitive tissues include mus-
cle, liver, adipose tissue, and the brain
(16). Because fasting measures primarily
reﬂect insulin suppression of hepatic glu-
cose production, they are mostly thought
to represent hepatic IS, whereas more in-
vasive measures are thought to be more
indicative of whole-body IS (17). The ob-
servation that HFF is related to both fast-
ingmeasuresandISinearlyTannerstages
suggests a signiﬁcant contribution of he-
patic IS to overall IS in prepurbertal and
early puberty. In the adolescent group,
H F Fw a sr e l a t e dt ob o t hf a s t i n gi n s u l i n
and IS in the African American girls, but
only to fasting insulin in the Hispanic
girls. The difference in the relative contri-
bution of hepatic IS to whole-body IS in
more advanced Tanner stages may ex-
plain the missing association of fasting
measures with IS in Hispanic girls. The
ethnic speciﬁc difference in the relation-
ship of fasting measures with whole-body
IS is in accordance with other studies
showing a better reﬂection of body IS
by fasting measures in African American
w o m e nc o m p a r e dw i t hn o n - H i s p a n i c
white women (9). Our results suggest
that ethnicity is an important compo-
nent in determining the clinical utility
of fasting measures as less invasive sur-
rogatesforIS.Thecurrentstudyextends
the comparison between fasting mea-
sures of IS and IS published by Alvarez
et al. (9) between non-Hispanic white
and African Americans to the Hispanic
ethnicity.
Inadditiontoethnicity,ourresultsdo
demonstrate the importance of pubertal
stage in the association of fasting mea-
sures with IS. Even though other publica-
tionsﬁndtherelationshipbetweenfasting
insulin and IS to be independent of
Tanner stage (18), the frequent ﬁnding
of a signiﬁcant effect of puberty on IS
(19) may contribute to the ﬁndings in
this article. All participants examined in
the current study were overweight. Other
work has discussed how the relationship
ofSIandfastingmeasuresmaydependon
speciﬁc characterizations of the group in-
vestigated, includingethnicity(9),weight
status (20), or health status (21). Our re-
sults underline that not only weight sta-
tus, but also ethnicity and pubertal status
playanimportantrolefortherelationship
of IS and fasting measures of IS.
The fasting measures examined in
this article are only a selection of possible
surrogates. Several measures based on
fasting insulin and glucose in children
and adolescents have been investigated
regardingtheirprosandconsassurrogate
measures for IS (10). Fasting insulin con-
centrationscanbehighlyvariablebecause
of serum half-life, cyclicity, and rapid re-
sponsiveness to hormonal and metabolic
milieu(21).Toaccountfor variability,we
used the mean of two fasted samples
taken separated by 5 min. Although this
is one less sample than recommended
by Matthews et al. (22), we found reli-
able correlations and consider the results
acceptable.
Fasting measures including HOMA-
IR are based on the assumption of a linear
relationship between glucose and insulin
concentrations. A linear relationship can
be observed with normal glucose toler-
ance, but not in participants with im-
paired fasting glucose (IFG) or impaired
glucose tolerance (IGT) (17). Fasting in-
sulin and fasting glucose were correlated
forboth ethnicitiesinTannerstages1and
2, but only in African American girls in
Tanner stages 4 and 5. The lack of rela-
tionship between fasting insulin and fast-
ing glucose in late pubertal Hispanic girls
may be an explanation for our discrep-
ancy in the relationship of IS and fasting
measures. The mismatch between fasting
insulin and glucose may well be because
of the higher HFF in the Hispanic group.
With a x
2 test, we examined whether
the Hispanic girls in Tanner stages 4 and 5
presented with higher frequency of IFG
Table 1—Participants’ characteristics separated by Tanner stage
Tanner stages 1 and 2 Tanner stages 4 and 5
African American Hispanic P African American Hispanic P
n 18 52 34 45
Age (years) 8.9 6 0.8 9.4 6 1.6 0.13 15.4 6 11 5 . 3 6 1 0.55
Height (cm) 141.6 6 5.9 137.1 6 11.1 0.08 165.4 6 7.8 158.9 6 15.4 0.02
Weight (kg) 46.0 6 11.6 41.3 6 12.7 0.13 98.9.623.5 86.5 6 18.5 0.01
BMI (kg/m
2) 22.9 6 5.1 25.1 6 4.2 0.11 36.1 6 83 3 . 8 6 6.9 0.19
Fat mass (kg) 14.6 6 6.6 15.6 6 8.3 0.59 35.9 6 12.4 35.7 6 10.9 0.93
FFM (kg) 33.02 6 6.0 28.9 6 8.0 0.05 54.6.67.9 48.8 6 8 0.00
SAT (L) 3.7 6 3.2 4.3 6 2.8 0.45 15.5 6 26.8 9.8 6 3.5 0.00
VAT (L) 0.35 6 0.33 0.73 6 0.60 0.02 1.2 6 0.8 1.3 6 0.8 0.35
HFF (%) 4.1 6 1.8 6.5 6 6.7 0.17 3.9 6 1.9 6.5 6 6.2 0.02
Fasting insulin (mU/mL) 11.9 6 9.9 13.6 6 10.8 0.54 20.7 6 10.1 21.3 6 11.9 0.79
Fasting glucose (mg/L) 87.5 6 6.7 92.6 6 5.4 0.00 87.9 6 6.4 91.5 6 5.5 0.01
IS [(3 10
24/min
21)/(mU/mL)] 3.0 6 1.8 3.3 6 1.8 0.59 1.3 6 0.8 1.6 6 0.8 0.10
DI (3 min
21) 3650 6 2024 2678 6 1148 0.01 2230 6 1456 1633 6 745 0.02
HOMA-IR 2.7 6 2.3 3.1 6 2.6 0.50 4.5 6 2.4 4.8 6 2.7 0.65
SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.
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Measures of insulin sensitivityFigure 1—Relationship of fasting insulin (A) and HOMA (B) with IS in Tanner stages 1 and 2.
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cordingtotherevisedcriteriaoftheWorld
Health Organization (23). The frequency
of both IFG and IGT was not different be-
tween ethnicities and thus cannot explain
our ﬁndings. The current study only in-
cluded girls because the Transitions study
only enrolled girls. It remains to be tested,
if our results hold, if both sexes are taken
into consideration.
In our adolescent participants, HFF
was signiﬁcantly higher in Hispanic
compared with African American girls,
which may possibly contribute to the
disruptionofarelationshipbetweenfasting
measures and IS in that ethnicity. Hepatic
fatisassociatedwithvisceralfatandinsulin
resistance, especially in Hispanic adoles-
cents (24,25). The individual fat depots in
Hispanics are only related to fasting mea-
sures,butnotIS,suggestingthattherelative
contributionofhepaticinsulinresistanceto
overall insulin resistance in Hispanic girls
is regulated differently compared with
African American girls. The results suggest
that IS and fasting measures equally reﬂect
overall IS in African American girls inde-
pendent of Tanner stage. Different com-
pensatory mechanisms for overall insulin
resistance between the ethnicities may
also play a role in the explanation for
the different relationship of fasting mea-
sures and IS in late puberty between eth-
nicities (5).
In association with the signiﬁcant
difference inHFFbetweenthe ethnicities,
one would expect differences in fasting
insulin and glucose concentrations as
well. While fasting insulin concentrations
werenotdifferentbetweentheethnicities,
fasting glucose was signiﬁcantly higher in
Hispanic girls. The limited power of fast-
ing insulin to suppress hepatic glucose
output also supports the idea of more
hepatic insulin resistance in the Hispanic
girls. The progressive failure of the b-cell
toadjusttotheincreasedinsulindemands
is evident in the signiﬁcantly lower b-cell
capacity (DI) in Hispanic girls.
A limitation of this study is that we
have no data on IS derived from a glucose
clamp in our group of participants. How-
ever, the FSIVGTT, especially the current
protocol including insulin administra-
tion,wasshowntoproduceresultsequiv-
alent to the euglycemic glucose clamp in
nondiabetic normal weight and obese
adults (7). Furthermore, the FSIVGTT
was shown to be a reliable measure in
children, even in a modiﬁed shortened
form (18).
In summary, the current study deliv-
ers evidence for the clinical value of
fasting measures of IS in prepubertal or
early puberty African American and His-
panic girls. More invasive measures are
necessary postpuberty to obtain an accu-
rate estimation of IS—at least in Hispanic
girls. Our results do emphasize the im-
portance of ethnicity and Tanner stage
as factors to consider when determining
the clinical usefulness of fasting measures
as an indicator for IS.
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Figure 2—Relationship of fasting insulin (A) and HOMA (B) with IS in Tanner stages 4 and 5.
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